Image 1 of 1
Research Benefits:
Synergistic GH Release: The CJC-1295 & Ipamorelin blend is widely used in research to evaluate the combined effect of a GHRH analog (CJC-1295) and a GH secretagogue (Ipamorelin) on endogenous growth hormone pulsatility.
Receptor Pathway Investigation: Ideal for studies analyzing the interaction between GHRH and ghrelin receptor pathways, supporting deeper insight into hormonal regulation and GH axis feedback mechanisms.
Endocrine Optimization Models: Used to explore hypothalamic-pituitary dynamics, particularly for understanding GH pulse frequency, amplitude, and downstream IGF-1 expression under dual-agonist stimulation.
Duration & Delivery Efficiency: CJC-1295 provides extended GH stimulation, while Ipamorelin offers rapid onset and receptor-specific action, allowing researchers to study both acute and prolonged hormone responses.
High-Purity Dual Peptide: This blend is synthesized with >99% purity in lyophilized form, designed for precision-based endocrine, metabolic, and biochemical laboratory testing.